Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
2.120
-0.580 (-21.48%)
May 6, 2025, 4:00 PM EDT - Market closed

Aldeyra Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
127297206408232266
Upgrade
Market Cap Growth
43.92%43.92%-49.34%75.40%-12.74%63.98%
Upgrade
Enterprise Value
4724079260132210
Upgrade
Last Close Price
2.704.993.516.964.006.86
Upgrade
PB Ratio
2.274.181.722.701.134.47
Upgrade
P/TBV Ratio
1.884.181.722.701.134.47
Upgrade
Debt / Equity Ratio
0.220.220.130.110.080.26
Upgrade
Quick Ratio
5.445.446.4211.568.904.26
Upgrade
Current Ratio
5.605.606.6411.7919.776.69
Upgrade
Return on Equity (ROE)
-58.54%-58.54%-27.73%-34.77%-43.56%-69.81%
Upgrade
Return on Assets (ROA)
-29.71%-29.71%-16.23%-18.91%-22.20%-27.28%
Upgrade
Return on Capital (ROIC)
-33.89%-33.89%-17.68%-20.16%-23.71%-31.48%
Upgrade
Earnings Yield
-41.95%-18.80%-18.18%-15.22%-24.86%-14.10%
Upgrade
FCF Yield
-32.45%-14.54%-14.69%-13.90%-18.32%-14.08%
Upgrade
Buyback Yield / Dilution
-0.92%-0.92%-0.92%-8.08%-59.11%-25.28%
Upgrade
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q